Type 2 tag sponsored by:
Type 2
-
Liver, renal, genitourinary and diabetic ketoacidosis risks among new users of empagliflozin versus dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes: Post-authorization safety study based on multinational cohorts
scholarlycommons.henryford.com | | Article Details | Related Articles